Metastatic Colorectal Cancer Pipeline Insight Analysis 2024, Featuring Emerging Drugs Mirati Therapeutics Adagrasib, Qilu Pharmaceutical QL-1203 and Zentalis Pharmaceuticals ZN-c3
April 25, 2024 04:05 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Metastatic colorectal cancer - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
Global Colorectal Cancer Pipeline Insights Report for 2024: An In-Depth Analysis of Clinical and Nonclinical Developments
April 23, 2024 07:28 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Colorectal Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The world is seeing an unprecedented increase...
Colorectal Cancer Research Report 2023: Eight Major Market Drug Forecasts and Market Analysis 2021-2031
February 19, 2024 10:01 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.Despite being a rare...
Colorectal Cancer Diagnostics and Therapeutics Market - Global Growth, Trends, and Forecasts to 2025
January 15, 2021 09:08 ET
|
Research and Markets
Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's...